PHV-wordings
Meloxicam
PSUR-outcome
|
12/05/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Ketorolac (systemic formulations)
PSUR-outcome
|
09/05/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Ifosfamide
PSUFU
|
17/04/2023
Further information is available on the HMA-Website.
Sufentanil
PSUR-outcome
|
14/04/2023
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Ropinirole
PSUR-outcome
|
14/04/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Voriconazole; Flucloxacillin
PRAC signal recommendation
|
13/04/2023
Risk for Drug interaction with flucloxacillin leading to subtherapeutic voriconazole levels. Further information and the changes to the product information in all EU languages are available on the EMA website.
Propofol
PRAC signal recommendation
|
13/04/2023
Risk for Medication errors that could potentially lead to life-threatening/fatal cases. Further information and the changes to the product information in all EU languages are available on the EMA website.
Carbetocin
PSUR-outcome
|
13/04/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Diltiazem
PSUR-outcome
|
24/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
Venlafaxine
PSUR-outcome
|
17/03/2023
Further information and amendments to the product information in all EU languages are available on the EMA website.
